Literature DB >> 35688469

Machine Learning-Derived Integer-Based Score and Prediction of Tertiary Hyperparathyroidism among Kidney Transplant Recipients: An Integer-Based Score to Predict Tertiary Hyperparathyroidism.

Namki Hong1, Juhan Lee2, Hyung Woo Kim3, Jong Ju Jeong4, Kyu Ha Huh5, Yumie Rhee6.   

Abstract

BACKGROUND AND OBJECTIVES: Tertiary hyperparathyroidism in kidney allograft recipients is associated with bone loss, allograft dysfunction, and cardiovascular mortality. Accurate pretransplant risk prediction of tertiary hyperparathyroidism may support individualized treatment decisions. We aimed to develop an integer score system that predicts the risk of tertiary hyperparathyroidism using machine learning algorithms. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We used two separate cohorts: a derivation cohort with the data of kidney allograft recipients (n=669) who underwent kidney transplantation at Severance Hospital, Seoul, Korea between January 2009 and December 2015 and a multicenter registry dataset (the Korean Cohort Study for Outcome in Patients with Kidney Transplantation) as an external validation cohort (n=542). Tertiary hyperparathyroidism was defined as post-transplant parathyroidectomy. The derivation cohort was split into 75% training set (n=501) and 25% holdout test set (n=168) to develop prediction models and integer-based score.
RESULTS: Tertiary hyperparathyroidism requiring parathyroidectomy occurred in 5% and 2% of the derivation and validation cohorts, respectively. Three top predictors (dialysis duration, pretransplant intact parathyroid hormone, and serum calcium level measured at the time of admission for kidney transplantation) were identified to create an integer score system (dialysis duration, pretransplant serum parathyroid hormone level, and pretransplant calcium level [DPC] score; 0-15 points) to predict tertiary hyperparathyroidism. The median DPC score was higher in participants with post-transplant parathyroidectomy than in those without (13 versus three in derivation; 13 versus four in external validation; P<0.001 for all). Pretransplant dialysis duration, pretransplant serum parathyroid hormone level, and pretransplant calcium level score predicted post-transplant parathyroidectomy with comparable performance with the best-performing machine learning model in the test set (area under the receiver operating characteristic curve: 0.94 versus 0.92; area under the precision-recall curve: 0.52 versus 0.47). Serial measurement of DPC scores (≥13 at least two or more times, 3-month interval) during 12 months prior to kidney transplantation improved risk classification for post-transplant parathyroidectomy compared with single-time measurement (net reclassification improvement, 0.28; 95% confidence interval, 0.02 to 0.54; P=0.03).
CONCLUSIONS: A simple integer-based score predicted the risk of tertiary hyperparathyroidism in kidney allograft recipients, with improved classification by serial measurement compared with single-time measurement. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Korean Cohort Study for Outcome in Patients with Kidney Transplantation (KNOW-KT), NCT02042963 PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2022_06_10_CJN15921221.mp3.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  artificial intelligence; calcium; hyperparathyroidism; machine learning; parathyroid hormone; transplant recipients; transplantation

Mesh:

Substances:

Year:  2022        PMID: 35688469      PMCID: PMC9269627          DOI: 10.2215/CJN.15921221

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   10.614


  19 in total

1.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

2.  Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function.

Authors:  Inger H Bleskestad; Harald Bergrem; Torbjørn Leivestad; Anders Hartmann; Lasse G Gøransson
Journal:  Clin Transplant       Date:  2014-03-19       Impact factor: 2.863

Review 3.  Parathyroidectomy in the Management of Secondary Hyperparathyroidism.

Authors:  Wei Ling Lau; Yoshitsugu Obi; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-09       Impact factor: 8.237

4.  Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism.

Authors:  Pablo Moreno; Ana Coloma; José V Torregrosa; Nuria Montero; José Francos; Sergi Codina; Anna Manonelles; Oriol Bestard; Arantxa García-Barrasa; Edoardo Melilli; Josep M Cruzado
Journal:  Clin Transplant       Date:  2020-06-03       Impact factor: 2.863

5.  Parathyroidectomy prior to kidney transplant decreases graft failure.

Authors:  Glenda G Callender; Jennifer Malinowski; Mahsa Javid; Yawei Zhang; Huang Huang; Courtney E Quinn; Tobias Carling; Ricarda Tomlin; J Douglas Smith; Sanjay Kulkarni
Journal:  Surgery       Date:  2016-11-15       Impact factor: 3.982

6.  High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation.

Authors:  Joke I Roodnat; Eveline A F J van Gurp; Paul G H Mulder; Teun van Gelder; Yolanda B de Rijke; Wouter W de Herder; Judith A Kal-van Gestel; Huib A P Pols; Jan N M Ijzermans; Willem Weimar
Journal:  Transplantation       Date:  2006-08-15       Impact factor: 4.939

7.  Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.

Authors:  Hege Pihlstrøm; Dag Olav Dahle; Geir Mjøen; Stefan Pilz; Winfried März; Sadollah Abedini; Ingar Holme; Bengt Fellström; Alan G Jardine; Hallvard Holdaas
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

8.  Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation.

Authors:  P Perrin; S Caillard; R M Javier; L Braun; F Heibel; C Borni-Duval; C Muller; J Olagne; B Moulin
Journal:  Am J Transplant       Date:  2013-08-26       Impact factor: 8.086

Review 9.  Management of hypercalcemia after renal transplantation.

Authors:  José-Vicente Torregrosa; Xoana Barros
Journal:  Nefrologia       Date:  2013-11-13       Impact factor: 2.033

10.  KNOW-KT (KoreaN cohort study for outcome in patients with kidney transplantation: a 9-year longitudinal cohort study): study rationale and methodology.

Authors:  Jaeseok Yang; Joongyup Lee; Kyu Ha Huh; Jae Berm Park; Jang-Hee Cho; Sik Lee; Han Ro; Seung-Yeup Han; Young Hoon Kim; Jong Cheol Jeong; Byung-Joo Park; Duck Jong Han; Sung-Bae Park; Wookyung Chung; Sung Kwang Park; Chan-Duck Kim; Sung Joo Kim; Yu Seun Kim; Curie Ahn
Journal:  BMC Nephrol       Date:  2014-05-09       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.